INVEST in FibroBiologics – Our Reg CF Offering is Now Open!
FOR SCIENTISTS ONLY: New articles added frequently.
The Science of Fibroblast Cell-Based Therapies
Thomas Ichim, Ph.D. led a team in a thorough analysis of the advantage fibroblasts exhibit over mesenchymal stem cells.
Howard An, M.D. leads a team of researchers who found that transplanting dermal fibroblasts can significantly increase the markers of disc regeneration and supported the hypothesis that the intervertebral disc is immune privileged. The study also suggests that fibroblast cell therapies can prevent the degeneration and promote the regeneration of the spinal disc.
A team of scientists led by Howard An, M.D. proves human dermal fibroblasts are a promising future for treatment of degenerative disc disease.
Thomas Ichim, Ph.D. led a team in a thorough analysis of the advantage fibroblasts exhibit over mesenchymal stem cells.
Howard An, M.D. leads a team of researchers who found that transplanting dermal fibroblasts can significantly increase the markers of disc regeneration and supported the hypothesis that the intervertebral disc is immune privileged. The study also suggests that fibroblast cell therapies can prevent the degeneration and promote the regeneration of the spinal disc.
A team of scientists led by Howard An, M.D. proves human dermal fibroblasts are a promising future for treatment of degenerative disc disease.
